UBASH3A Antikörper (AA 470-482)
Kurzübersicht für UBASH3A Antikörper (AA 470-482) (ABIN5539592)
Target
Alle UBASH3A Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- AA 470-482
-
Verwendungszweck
- STS2 / TULA (aa470-482)
-
Sequenz
- DSGIRISSVF ASP
-
Spezifität
- This antibody is expected to recognize both reported isoforms (NP_061834.1, NP_001001895.1).
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: In paraffin embedded Human Breast shows perinuclear staining in the epithelial cells of the lubules. Recommended concentration, 3-5 μg/mL.
Western Blot: Approx 70 kDa band observed in Human Spleen lysates (calculated MW of 69.8 kDa according to NP_001001895.1). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:8000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- UBASH3A (Ubiquitin Associated and SH3 Domain Containing, A (UBASH3A))
-
Andere Bezeichnung
- UBASH3A
-
Hintergrund
- UBASH3A, ubiquitin associated and SH3 domain containing A, CLIP4, STS-2, TULA, OTTHUMP00000109368, T-cell ubiquitin ligand protein, cbl-interacting protein 4, suppressor of T-cell receptor signaling 2, ubiquitin-associated and SH3 domain-containing protei
-
Gen-ID
- 53347
-
NCBI Accession
- NP_061834, NP_001001895
Target
-